stock
ARTV · Artiva Biotherapeutics, Inc.
What Artiva Biotherapeutics, Inc. reports to the SEC, read from its filings.
Open in the appPrice
The live ARTV price and today's change.
Sign in to see thisChart
Thirty days of daily bars, with signal levels drawn on them.
Sign in to see thisSignals
The latest signal group Nakagai's scanner recorded on ARTV.
Sign in to see thisOptions positioning
Gamma exposure levels from the options market.
Sign in to see thisTechnicals
Trend, momentum and volatility gauges per timeframe.
Sign in to see thisWhat it is
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Filer (SEC EDGAR)
- EDGAR filing index
- Shares outstanding
- 48,890,121 as of 2026-07-31 (XBRL frame CY2026Q2I)
Key stats
Valuation
- P/E
- Locked
- P/S
- Locked
- P/B
- Locked
- Enterprise value
- Locked
- EV/EBIT
- Locked
- FCF yield
- Locked
Margins
- Gross
- —
- Operating
- —
- Net
- —
Returns
- ROE
- -26.1%
- ROA
- -24.6%
Health
- Current ratio
- 24.2x
- Debt/equity
- —
Deep value
- NCAV
- $331.14M
- NCAV per share
- $6.77
- Price/NCAV
- Locked
- NNWC
- $280.32M
- NNWC per share
- $5.73
- Price/NNWC
- Locked
Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.
Sign in to see thisDebt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.
Results
| Period end | Revenue | Gross profit (not reported by this company) | Operating income | Net income | Filing |
|---|---|---|---|---|---|
| 2026-06-30 | — | —Gross profit: unreported by this company. | -$26.89M | -$25.00M | 10-Q filed 2026-08-06 |
| 2026-03-31 | — | —Gross profit: unreported by this company. | -$24.43M | -$23.52M | 10-Q filed 2026-08-06 Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-12-31 | — | —Gross profit: unreported by this company. | -$21.93M | -$20.77M | 10-K filed 2026-03-10 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. |
| 2025-09-30 | — | —Gross profit: unreported by this company. | -$22.90M | -$21.53M | 10-Q filed 2025-11-12 |
| 2025-06-30 | — | —Gross profit: unreported by this company. | -$22.81M | -$21.25M | 10-Q filed 2026-08-06 |
| 2025-03-31 | — | —Gross profit: unreported by this company. | -$22.17M | -$20.31M | 10-Q filed 2026-08-06 Assembled from more than one filing; the filing above is only the newest of them. |
| 2024-12-31 | — | —Gross profit: unreported by this company. | -$18.27M | -$16.09M | 10-K filed 2026-03-10 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. |
| 2024-09-30 | — | —Gross profit: unreported by this company. | -$18.34M | -$17.47M | 10-Q filed 2025-11-12 |
- Assets
- $368.63M
- Equity
- $347.50M
Balance as of 2026-06-30.
Ten years
| Fiscal year end | Revenue | Operating income | Net income | Free cash flow |
|---|---|---|---|---|
| 2025-12-31 | $0 | -$89.81M | -$83.86M | -$79.34M |
| 2024-12-31 | $251,000 | -$67.28M | -$65.37M | -$55.67M |
| 2023-12-31 | $32.92M | -$30.67M | -$28.72M | -$50.69M |
Company filings
since Thu Aug 6 · 1 offering filing in 12 months · since Fri May 8
events
Executive or director change, Shareholder vote results
Executive or director changeShareholder vote resultsSep 118-KResults
ResultsAug 68-KOther event
Other eventJul 228-KExecutive or director change
Executive or director changeMay 198-KOther event
Other eventMay 88-KResults, Regulation FD disclosure, Other event
ResultsRegulation FD disclosureOther eventMay 88-K
5% owners ()
Venrock Healthcare Capital Partners III, L.P.
Stake update
5AM Ventures VI, L.P.
Stake update
RA Capital Management, L.P.
Stake update
RA Capital Management, L.P.
Stake update
GC Corp
Stake update
Insiders, politicians and funds
Insider trades, last 90 days
Aslan Fred
Chief Executive Officer, Director
Sale$255,746Sep 9, 4:02 PM ET
Horan Christopher
Chief Tech Operations Officer
Sale$115,638Sep 4, 4:04 PM ET
Bush Jennifer
COO, CLO, Compliance Officer
Sale$93,606Sep 4, 4:03 PM ET
Banerjee Subhashis
Chief Medical Officer
Sale$12,271Sep 4, 4:03 PM ET
Aslan Fred
Chief Executive Officer, Director
Sale$690,392Sep 4, 4:02 PM ET
Politician trades, last 90 days
No politician trades filed in the last 90 days.
Funds
- Viking Global
Period Tue 30 Jun 2026
0.1%New
News
Stories that named ARTV, and the market events around them.
Sign in to see thisBoard
The ARTV board could not be loaded.
Retry the ARTV boardnakagai
Signals on ARTV come from a rule, not a model.
Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.
Members post on the ARTV board